Clinical Trial Update: Preoperative Fulvestrant With or Without Enzalutamide in ER+/Her2- Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating preoperative fulvestrant with or without enzalutamide in ER-positive, HER2-negative breast cancer; registry indicates results were post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Enzalutamide (enzalutamide)
• Fulvestrant (fulvestrant)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-06-15